The Week That Was in ASEAN@Smartkarma - CPALL, Arwana Citramulia, and Sido Muncul
The past week saw insights on CP ALL PCL (CPALL TB), Arwana Citramulia (ARNA IJ), Sido Muncul (SIDO IJ), and AvePoint (AVPT US)
262 Views
APAC Healthcare Weekly (Jan 26)- Daiichi Sankyo, Sumitomo Pharma, Fosun Pharma, SK Bioscience, Hugel
APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...
486 Views
Thematic Report: Changing Indian Pharma Landscape: Patents, USFDA, Policy Support
​India is a global pharmaceutical leader, supplying a significant portion of generic drugs and vaccines, with projections reaching $450 billion by...
498 Views
Suraksha Diagnostic IPO: Premium Valuation Limits Near-Term Upside Potential
​Suraksha Diagnostic offers integrated pathology and radiology services in India. The IPO comprises of an OFS of up to 19M shares. The company has...
666 Views
HSIE Results Daily: SBI Life Insurance, Godrej Properties, SRF, AU Small Finance Bank
SBILIFE’s H1FY25 VNB printed at INR24.2bn (+2.5% YoY), as the VNB margin softened to 26.8% (-180bps YoY) on the back of a higher share of ULIP in...
297 Views